Hôpital le Vinatier   Report issue

Academic/Hospital Phase 2
Founded: Bron France (1876)

Organization Overview

First Clinical Trial
2018
NCT03492970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Centre hospitalier le Vinatier | Centre Hospitalier Le Vinatier - CRNL - INSERM | CH LE VINATIER | Hôpital le Vinatier | hospital le vinatier

Active Ingredients

Drugs in Phase 2 Trials (1)

cannabidiol (Epidiolex) (1 trial)

Drugs in Other Trials (2)

cannabis (1 trial)

melatonin (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3